 |
|
Processed Costal Cartilage Homograft in RhinoplastyThe Asan Medical Center Experience
Hyung Min Song, MD;
Bong-Jae Lee, MD, PhD;
Yong Ju Jang, MD, PhD
Arch Otolaryngol Head Neck Surg. 2008;134(5):485-489.
Objective To report our experience using a commercially available homograft (Tutoplast-processed costal cartilage [TPCC]; Tutogen Medical GmbH, Neunkirchen am Brand, Germany) in augmentation rhinoplasty.
Design Retrospective review.
Setting Tertiary care academic center.
Patients The study population comprised 35 patients who underwent rhinoplasty with TPCC between November 2003 and October 2004.
Interventions The TPCCs were used for full-length dorsal grafts in all 35 patients, as well as for septal batten, spreader graft, septal extension, tip onlay, and shield grafts.
Main Outcome Measures Surgical outcomes were evaluated in 35 patients who underwent rhinoplasty in which TPCC was used. Anthropometric measurements of the nose were made on lateral photographs and compared with preoperative measurements. Postoperative complications were also assessed.
Results Anthropometric measurements, expressed as mean (SD), documented postoperative increases in tip projection (5% [9%]), nasal length (10% [10%]), nasolabial angle (1.5° [8.7°]), and nasofrontal angle (3.1° [8.7°]). The overall complication rate was 31% (11 of 35 patients). Complications included resorption (17%), warping (9%), visible graft contour (3%), and graft fracture (3%).
Conclusion Although TPCC could serve as an alternative graft material for rhinoplasty, the high complication rates of this material may preclude its use for dorsal augmentation.
Author Affiliations: Department of Otolaryngology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, South Korea.
|
